Buscar
Mostrando ítems 1-10 de 11417
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
The global pandemic of COVID-19 caused by SARS-CoV-2 (also known as 2019-nCoV and HCoV-19) has
posed serious threats to public health and economic stability worldwide, thus calling for development of
vaccines against ...
Dynamics of the ACE2–SARS‐CoV‐2/ SARS‐CoV spike protein interface reveal unique mechanisms
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a major public health concern.A handful of static structures now
provide molecular insights ...
COVID-19: From bench to bed side
Background and aims: The last two decades have experienced the outbreaks of three different coronaviruses in the different parts of the world namely; Severe acute respiratory syndrome cornonavirus-1
(SARS-CoV-1), Middle ...
Profiling and characterization of SARS-CoV-2 mutants’ infectivity and antigenicity
Using high-throughput pseudovirus assay in conjunction with
neutralizing antibodies, Wang et al. investigated 80 natural
variants and 26 glycosylation-spike (S) mutants of SARS-CoV-2 in
terms of infectivity and ...
Vacunas contra el SARS-CoV-2
(2021)
Controversy around SARS-CoV-2 Reinfections
[Abstract not available]
Detección del SARS-CoV-2 mediante RT-qPCR utilizando saliva en pacientesambulatorios con estudio de COVID-19
(2022)
La pandemia de COVID-19 ha afectado a millonesde personas en todo el mundo. La identificación de sujetos infectadosha sido importante para el control. Objetivo: Evaluar el rendimiento deuna reacción de polimerasa en cadena ...
SARS-CoV-2’s Variants of Concern: A Brief Characterization
(Frontiers Media, 2023)
SARS-CoV, MERS-CoV and SARS-CoV-2: a diagnostic challenge
(Elsevier, 2020)